Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: Used. pp. xviii + 750 1st Edition.
EUR 191,63
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. xviii + 750 Illus.
EUR 193,96
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Used. pp. xviii + 750.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 223,72
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 219,37
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical trials in both resectable and metastatic pancreatic cancer have been completed, raising new questions about the standard of care in this disease. Finally, the era of targeted biologic therapies has engendered new excitement about the prospects of more rapid progress in understanding and successfully treating this dreadful disease. Therefore, it is an appropriate time to review these important advances and outline areas of controversy and question in pancreatic cancer biology and treatment.
EUR 311,84
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 750 pages. 9.50x6.50x1.50 inches. In Stock.
Da: moluna, Greven, Germania
EUR 175,51
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Pancreatic Cancer brings to the forefront the most current advances that have been made in understanding pancreatic cancer development and successfully treating this dreadful disease. This volume provides information on the recent progress and improvements .
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 213,99
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. This book provides information on the recent progress and improvements. It brings to the forefront the most current advances that have been made in understanding pancreatic cancer development and successfully treating this disease. 764 pp. Englisch.
Da: preigu, Osnabrück, Germania
EUR 181,95
Quantità: 5 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Pancreatic Cancer | Andrew M. Lowy (u. a.) | Buch | xviii | Englisch | 2008 | Copernicus | EAN 9780387692500 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Lingua: Inglese
Editore: Springer US, Copernicus Aug 2008, 2008
ISBN 10: 0387692509 ISBN 13: 9780387692500
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 213,99
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical trials in both resectable and metastatic pancreatic cancer have been completed, raising new questions about the standard of care in this disease. Finally, the era of targeted biologic therapies has engendered new excitement about the prospects of more rapid progress in understanding and successfully treating this dreadful disease. Therefore, it is an appropriate time to review these important advances and outline areas of controversy and question in pancreatic cancer biology and treatment.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 764 pp. Englisch.